levophacetoperane

RN given refers to (R*,R*)-(-)-isomer

Also Known As:

HCl(R*,R*)-(-)-isomer of levophacetoperane; alpha-phenyl-2-piperidinemethanol acetate; levofacetoperane; lidepran; phacetoperane

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Obesity 01/01/2024 - "Launched in Canada and Europe by Specia Rhône-Poulenc and Rhodia, marketed as Lidepran® (8228 R.P.), for the treatment of obesity and depression, phacetoperane became an increasingly popular psychiatric medication from 1959 to 1967. "
2.	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/01/2024 - "NLS-3 or (R, R) enantiomer of phacetoperane (levophacetoperane) is the reverse ester of methylphenidate, a well-documented psychostimulant marketed for the treatment of attention-deficit/hyperactivity disorder (ADHD) since the end of 1950s. "